| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 15/07/2015 | 17:02 | PR Newswire (US) | Stull, Stull & Brody Launches Investigation Into Possible Breaches of Fiduciary Duty by the Board of Directors of Receptos, I... | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 16:37 | PR Newswire (US) | RECEPTOS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Receptos, Inc. (RCPT) Over the Proposed Sale... | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 15:00 | PR Newswire (US) | Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Receptos, Inc. Concerning its Proposed Sale to ... | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 12:05 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 01:52 | PR Newswire (US) | Robbins Arroyo LLP: Acquisition of Receptos, Inc. (RCPT) by Celgene Corporation (CELG) May Not Be in Shareholders' Best Inter... | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 01:50 | Dow Jones News | Celgene to Buy Receptos for $7.2 Billion | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 01:36 | Dow Jones News | Celgene to Buy Receptos for $7.2 Billion--3rd Update | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 00:37 | Dow Jones News | Celgene to Buy Receptos for About $7.2 Billion--2nd Update | NASDAQ:RCPT | (MM) |
| 15/07/2015 | 00:18 | Dow Jones News | Celgene to Buy Receptos for About $7.2 Billion--Update | NASDAQ:RCPT | (MM) |
| 14/07/2015 | 23:50 | Dow Jones News | Celgene to Buy Receptos for About $7.2 Billion | NASDAQ:RCPT | (MM) |
| 14/07/2015 | 23:46 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Receptos, Inc. of Commencement of an Investigation Concerni... | NASDAQ:RCPT | (MM) |
| 14/07/2015 | 23:28 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:RCPT | (MM) |
| 14/07/2015 | 23:27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCPT | (MM) |
| 14/07/2015 | 22:58 | Business Wire | Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases | NASDAQ:RCPT | (MM) |
| 13/07/2015 | 15:55 | The Motley Fool | 5 Drugs That Investors May Be Undervaluing | NASDAQ:RCPT | (MM) |
| 02/07/2015 | 18:11 | The Motley Fool | Why Shares in Receptos Soared 15% in June | NASDAQ:RCPT | (MM) |
| 12/06/2015 | 00:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RCPT | (MM) |
| 11/06/2015 | 22:05 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:RCPT | (MM) |
| 02/06/2015 | 15:06 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:RCPT | (MM) |
| 15/05/2015 | 14:00 | GlobeNewswire Inc. | Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015 | NASDAQ:RCPT | (MM) |
| 14/05/2015 | 14:00 | GlobeNewswire Inc. | Receptos to Present at UBS Global Healthcare Conference | NASDAQ:RCPT | (MM) |
| 07/05/2015 | 14:00 | GlobeNewswire Inc. | Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare Conference | NASDAQ:RCPT | (MM) |
| 06/05/2015 | 22:18 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCPT | (MM) |
| 06/05/2015 | 16:28 | Analyst Ratings Network | Receptos PT Raised to $202.00 (RCPT) | NASDAQ:RCPT | (MM) |
| 05/05/2015 | 22:01 | GlobeNewswire Inc. | Receptos Provides Business Update and Reports First Quarter 2015 Financial Results | NASDAQ:RCPT | (MM) |
| 29/04/2015 | 14:00 | GlobeNewswire Inc. | Receptos to Hold First Quarter 2015 Results Conference Call | NASDAQ:RCPT | (MM) |
| 19/04/2015 | 17:07 | The Motley Fool | 3 Biotech Stocks That Could Be Developing Billion Dollar Drugs | NASDAQ:RCPT | (MM) |
| 17/04/2015 | 22:10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:RCPT | (MM) |
| 17/04/2015 | 22:07 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:RCPT | (MM) |
| 16/04/2015 | 14:00 | GlobeNewswire Inc. | Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Coliti... | NASDAQ:RCPT | (MM) |